Abstract

The mechanism underlying increased concentrations of cancer stem cell (CSC)-associated factors in non-small cell lung cancer (NSCLC) cells treated with transforming growth factor β1 (TGFβ1) and tumor necrosis factor α (TNFα), is still not clear. The purpose of this study was to investigate the possible role of CD44 in the regulation of CSC-associated genes, by analyzing the effect of CD44 knockdown on their expression. A549, a NSCLC cell line that expresses CD44 antigen, was treated with TGFβ1 and TNFα. Small-interfering ribonucleic acid (siRNA) that specifically targets the CD44 gene was used to knockdown the expression of CD44 in A549. The gene expressions of CD44, CXCR4, POU5F1 (octamer-binding transcription factor 4 [Oct4]), PROM1, NANOG, c-Myc, KLF4, and SOX2, as well as of CDH1 (E-cadherin), CDH2 (N-cadherin), VIM (vimentin), and FN1 (fibronectin) were analyzed in A549 cells by quantitative reverse transcription polymerase chain reaction (RT-qPCR). Cell morphology was observed using light microscopy. After TGFβ1/TNFα treatment, increased expressions of CXCR4 and POU5F1 were detected. Silencing of CD44 gene expression was confirmed by RT-qPCR. The knockdown of CD44 decreased the CXCR4 and POU5F1 gene expressions in TGFβ1/TNFα-treated A549 cells. However, the silencing of CD44 did not affect the morphology of TGFβ1/TNFα-treated A549 cells nor it reversed epithelial-mesenchymal transition (EMT) gene signature induced by TGFβ1/TNFα in A549 cells. Our preliminary findings suggest that the CD44 gene may have a role in regulating CXCR4 and POU5F1 gene expressions, independently of the EMT signaling pathway.

Highlights

  • Cancer stem cells (CSCs) are a minor population of tumor cells that have the ability to self-renew

  • Our results showed upregulated expression of CXCR4 and POU5F1 in transforming growth factor β1 (TGFβ1)/tumor necrosis factor α (TNFα)-treated A549 cells (Figure 1), no increase was observed in the expression of CD133, NANOG, c-Myc, KLF4, and SOX2 genes

  • Knockdown of CD44 reduced the expression of CXCR4 and POU5F1 in TGFβ1/TNFα-treated A549 cells

Read more

Summary

Introduction

Cancer stem cells (CSCs) are a minor population of tumor cells that have the ability to self-renew. Dysregulation of this stem cell self-renewal process is likely a basis for the development of cancer [1]. CSC markers have been reported in different cancer types, including CD44 [4,5,6], C-X-C chemokine receptor type 4 (CXCR4) [7], and octamer-binding transcription factor 4 (Oct4) [8]. CD44 was first reported as a CSC marker by Al-Hajj et al in 2003 [6], and since has been extensively investigated in cancers of various organs. In non-small cell lung cancer (NSCLC) it was reported that the cells expressing CD44 have stem cell-like characteristics [9]. We previously reported that the interaction between CD44 and its ligand hyaluronate in NSCLC cells in which CD44 was reintroduced

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.